Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

BACKGROUND: The decline of humoral response to COVID-19 vaccine led to authorise a booster dose. Here, we characterised the kinetics of B-cell and T-cell immune responses in patients with multiple sclerosis (PwMS) after the booster dose. METHODS: We enrolled 22 PwMS and 40 healthcare workers (HCWs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiello, Alessandra, Coppola, Andrea, Ruggieri, Serena, Farroni, Chiara, Altera, Anna Maria Gerarda, Salmi, Andrea, Vanini, Valentina, Cuzzi, Gilda, Petrone, Linda, Meschi, Silvia, Lapa, Daniele, Bettini, Aurora, Haggiag, Shalom, Prosperini, Luca, Galgani, Simonetta, Quartuccio, Maria Esmeralda, Bevilacqua, Nazario, Garbuglia, Anna Rosa, Agrati, Chiara, Puro, Vincenzo, Tortorella, Carla, Gasperini, Claudio, Nicastri, Emanuele, Goletti, Delia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086471/
https://www.ncbi.nlm.nih.gov/pubmed/36522154
http://dx.doi.org/10.1136/jnnp-2022-330175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086471/
https://www.ncbi.nlm.nih.gov/pubmed/36522154
http://dx.doi.org/10.1136/jnnp-2022-330175

Ejemplares similares